Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesko

Showing results (891-900 of 1,126) with videos related to

Pageof 113
Sort By:
Human Molecular Genetics|June 3, 2026
MRPS22 variants alter mitochondrial ribosome assembly in patients with leukodystrophy, movement disorder and intellectual impairmentRuth I C Glasgow, Finn Lennartsson, Snjolaug Arnardottir, et al.
Clinical Pharmacology and Therapeutics|December 31, 2010
Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory reviewP Zhao, L Zhang, J A Grillo, et al.
Annals of Epidemiology|September 23, 2023
Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation studyParastu Kasaie, Cameron Stewart, Elizabeth Humes, et al.
American Journal of Epidemiology|April 13, 2026
New to Cohort, Not New to Care: Leveraging Historical Data in HIV Clinical Cohorts in the United StatesNel Jason L Haw, Brenna Hogan, Elizabeth Humes, et al.
Clinical Pharmacology and Therapeutics|January 30, 2007
Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006V A Bhattaram, C Bonapace, D M Chilukuri, et al.
Parkinsonism & Related Disorders|May 8, 2021
Comparison in detection of prodromal Parkinson's disease patients using original and updated MDS research criteria in two independent cohortsKristina Kulcsarova, Joaquim Ribeiro Ventosa, Eva Feketeova, et al.
Clinical Pharmacology and Therapeutics|December 20, 2007
A prototypical process for creating evidentiary standards for biomarkers and diagnosticsC A Altar, D Amakye, D Bounos, et al.
Journal of Clinical Pharmacology|January 11, 2012
Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulationPing Zhao, Manuela de L T Vieira, Joseph A Grillo, et al.
The Journal of Infectious Diseases|May 30, 2026
Weight Gain on Contemporary Integrase Strand Transfer Inhibitors and Tenofovir Alafenamide in Persons with HIV Starting Antiretroviral Therapy in the United States and CanadaKassem Bourgi, Aihua Bian, Lakeisha Boyd, et al.
Skin Pharmacology and Applied Skin Physiology|May 29, 1998
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. AAPS/FDA Workshop on 'Bioequivalence of Topical Dermatological Dosage Forms-- Methods of Evaluating Bioequivalence', September 4-6, 1996, Bethesda, MdV P Shah, G L Flynn, A Yacobi, et al.
Pageof 113

Showing results (891-900 of 1,126) with videos related to

Sort By:
Pageof 113
Human Molecular Genetics|June 3, 2026
MRPS22 variants alter mitochondrial ribosome assembly in patients with leukodystrophy, movement disorder and intellectual impairmentRuth I C Glasgow, Finn Lennartsson, Snjolaug Arnardottir, et al.
Clinical Pharmacology and Therapeutics|December 31, 2010
Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory reviewP Zhao, L Zhang, J A Grillo, et al.
Annals of Epidemiology|September 23, 2023
Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation studyParastu Kasaie, Cameron Stewart, Elizabeth Humes, et al.
American Journal of Epidemiology|April 13, 2026
New to Cohort, Not New to Care: Leveraging Historical Data in HIV Clinical Cohorts in the United StatesNel Jason L Haw, Brenna Hogan, Elizabeth Humes, et al.
Clinical Pharmacology and Therapeutics|January 30, 2007
Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006V A Bhattaram, C Bonapace, D M Chilukuri, et al.
Parkinsonism & Related Disorders|May 8, 2021
Comparison in detection of prodromal Parkinson's disease patients using original and updated MDS research criteria in two independent cohortsKristina Kulcsarova, Joaquim Ribeiro Ventosa, Eva Feketeova, et al.
Clinical Pharmacology and Therapeutics|December 20, 2007
A prototypical process for creating evidentiary standards for biomarkers and diagnosticsC A Altar, D Amakye, D Bounos, et al.
Journal of Clinical Pharmacology|January 11, 2012
Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulationPing Zhao, Manuela de L T Vieira, Joseph A Grillo, et al.
The Journal of Infectious Diseases|May 30, 2026
Weight Gain on Contemporary Integrase Strand Transfer Inhibitors and Tenofovir Alafenamide in Persons with HIV Starting Antiretroviral Therapy in the United States and CanadaKassem Bourgi, Aihua Bian, Lakeisha Boyd, et al.
Skin Pharmacology and Applied Skin Physiology|May 29, 1998
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. AAPS/FDA Workshop on 'Bioequivalence of Topical Dermatological Dosage Forms-- Methods of Evaluating Bioequivalence', September 4-6, 1996, Bethesda, MdV P Shah, G L Flynn, A Yacobi, et al.
Pageof 113